NIH #1R01AR086381-01
Development of Dual-Action Nanoparticle-Loaded Microparticles for Osteoarthritis Treatment
Active
- Amount
- $647K
- Period
- 2025-09-05 → 2030-06-30
- PIs
- 1
- Est. capacity / PI
- ~8 students
Awarded at UNIVERSITY OF PENNSYLVANIA
NIH #1R01CA289624-01
Transcriptional Reprogramming in Melanoma Plasticity
Active
- Amount
- $615K
- Period
- 2024-07-18 → 2029-06-30
- PIs
- 1
- Est. capacity / PI
- ~6 students
Awarded at WISTAR INSTITUTE
NIH #5R01AR080820-04
Treating knee osteoarthritis by sPLA2 inhibitor-loaded micellar nanoparticles
Active
- Amount
- $458K
- Period
- 2022-04-01 → 2028-03-31
- PIs
- 1
- Est. capacity / PI
- ~2 students
Awarded at UNIVERSITY OF PENNSYLVANIA
NIH #3R01AR080820-03S1
Treating knee osteoarthritis by sPLA2 inhibitor-loaded micellar nanoparticles
Active
- Amount
- $89K
- Period
- 2022-04-01 → 2028-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PENNSYLVANIA
NIH #5R01AR080820-03
Treating knee osteoarthritis by sPLA2 inhibitor-loaded micellar nanoparticles
Active
- Amount
- $503K
- Period
- 2022-04-01 → 2028-03-31
- PIs
- 1
- Est. capacity / PI
- ~2 students
Awarded at UNIVERSITY OF PENNSYLVANIA
NIH #5R01AR080820-02
Treating knee osteoarthritis by sPLA2 inhibitor-loaded micellar nanoparticles
Active
- Amount
- $524K
- Period
- 2022-04-01 → 2028-03-31
- PIs
- 1
- Est. capacity / PI
- ~2 students
Awarded at UNIVERSITY OF PENNSYLVANIA
NIH #5R01CA140964-16
Autophagy-mediated defense against inflammation and cancer
Active
- Amount
- $435K
- Period
- 2009-09-21 → 2027-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at WISTAR INSTITUTE
NIH #3R01AR080820-04S1
Treating knee osteoarthritis by sPLA2 inhibitor-loaded micellar nanoparticles
Active
- Amount
- $89K
- Period
- 2022-04-01 → 2027-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PENNSYLVANIA
NIH #5R01CA262631-05
New control of oncogene activation in T-cell leukemia
Active
- Amount
- $530K
- Period
- 2022-04-12 → 2027-03-31
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at WISTAR INSTITUTE
NIH #5R01CA262631-04
New control of oncogene activation in T-cell leukemia
Active
- Amount
- $525K
- Period
- 2022-04-12 → 2027-03-31
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at WISTAR INSTITUTE
NIH #5R01CA262631-03
New control of oncogene activation in T-cell leukemia
Active
- Amount
- $493K
- Period
- 2022-04-12 → 2027-03-31
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at WISTAR INSTITUTE
NIH #3R01AR080820-02S1
Treating knee osteoarthritis by sPLA2 inhibitor-loaded micellar nanoparticles
Active
- Amount
- $68K
- Period
- 2022-04-01 → 2027-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PENNSYLVANIA
NIH #5R01CA262631-02
New control of oncogene activation in T-cell leukemia
Active
- Amount
- $504K
- Period
- 2022-04-12 → 2027-03-31
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at WISTAR INSTITUTE
NIH #1R01AR080820-01
Treating knee osteoarthritis by sPLA2 inhibitor-loaded micellar nanoparticles
Active
- Amount
- $532K
- Period
- 2022-04-01 → 2027-03-31
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at UNIVERSITY OF PENNSYLVANIA
NIH #1R01CA262631-01A1
New control of oncogene activation in T-cell leukemia
Active
- Amount
- $542K
- Period
- 2022-04-12 → 2027-03-31
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at WISTAR INSTITUTE
NIH #5R01CA289624-02
Transcriptional Reprogramming in Melanoma Plasticity
- Amount
- $594K
- Period
- 2024-07-18 → 2026-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at WISTAR INSTITUTE
NIH #5R01CA140964-15
Autophagy-mediated defense against inflammation and cancer
- Amount
- $413K
- Period
- 2009-09-21 → 2026-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at WISTAR INSTITUTE
NIH #5R01CA140964-14
Autophagy-mediated defense against inflammation and cancer
- Amount
- $435K
- Period
- 2009-09-21 → 2026-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at WISTAR INSTITUTE
NIH #5R01CA140964-13
Autophagy-mediated defense against inflammation and cancer
- Amount
- $426K
- Period
- 2009-09-21 → 2026-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at WISTAR INSTITUTE
NIH #2R01CA140964-12A1
Autophagy-mediated defense against inflammation and cancer
- Amount
- $416K
- Period
- 2009-09-21 → 2026-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at WISTAR INSTITUTE
NIH #5R01CA238457-06
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC
- Amount
- $549K
- Period
- 2020-08-06 → 2025-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at WISTAR INSTITUTE
NIH #5R01ES029092-06
Molecular Mechanism of UV Protection in Cutaneous Melanoma
- Amount
- $622K
- Period
- 2020-07-29 → 2024-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at WISTAR INSTITUTE
NIH #5R01CA238457-05
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC
- Amount
- $570K
- Period
- 2020-08-06 → 2024-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at WISTAR INSTITUTE
NIH #5R01CA238457-04
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC
- Amount
- $566K
- Period
- 2020-08-06 → 2024-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at WISTAR INSTITUTE
NIH #5R01CA238457-03
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC
- Amount
- $577K
- Period
- 2020-08-06 → 2024-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at WISTAR INSTITUTE
NIH #7R01CA238457-02
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC
- Amount
- $430K
- Period
- 2020-08-06 → 2024-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at WISTAR INSTITUTE
NIH #5R01ES029092-05
Molecular Mechanism of UV Protection in Cutaneous Melanoma
- Amount
- $622K
- Period
- 2020-07-29 → 2023-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at WISTAR INSTITUTE
NIH #5R01ES029092-04
Molecular Mechanism of UV Protection in Cutaneous Melanoma
- Amount
- $622K
- Period
- 2020-07-29 → 2023-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at WISTAR INSTITUTE
NIH #7R01ES029092-03
Molecular Mechanism of UV Protection in Cutaneous Melanoma
- Amount
- $440K
- Period
- 2020-07-29 → 2023-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at WISTAR INSTITUTE
NIH #1R01ES029092-01A1
Molecular Mechanism of UV Protection in Cutaneous Melanoma
- Amount
- $557K
- Period
- 2019-01-01 → 2023-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF SOUTHERN CALIFORNIA
NIH #5R01NS100892-05
Targeted treatment for radiculopathy via engineered PLA2-responsive multifunctional micelles
- Amount
- $346K
- Period
- 2017-09-01 → 2023-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PENNSYLVANIA
NIH #5R01NS100892-04
Targeted treatment for radiculopathy via engineered PLA2-responsive multifunctional micelles
- Amount
- $346K
- Period
- 2017-09-01 → 2022-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PENNSYLVANIA
NIH #5R01NS100892-03
Targeted treatment for radiculopathy via engineered PLA2-responsive multifunctional micelles
- Amount
- $345K
- Period
- 2017-09-01 → 2022-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PENNSYLVANIA
NIH #5R01NS100892-02
Targeted treatment for radiculopathy via engineered PLA2-responsive multifunctional micelles
- Amount
- $344K
- Period
- 2017-09-01 → 2022-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PENNSYLVANIA
NIH #1R01NS100892-01A1
Targeted treatment for radiculopathy via engineered PLA2-responsive multifunctional micelles
- Amount
- $344K
- Period
- 2017-09-01 → 2022-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PENNSYLVANIA
NIH #7R21DE028256-03
Targeting the host NDP kinase to abrogate viral dissemination
- Amount
- $136K
- Period
- 2020-07-27 → 2021-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at WISTAR INSTITUTE
NIH #7R01CA140964-11
Novel mechanism for UVRAG in genome stability and tumor suppression
- Amount
- $124K
- Period
- 2009-09-21 → 2021-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at WISTAR INSTITUTE
NIH #1R21DE028256-01
Targeting the host NDP kinase to abrogate viral dissemination
- Amount
- $248K
- Period
- 2019-01-04 → 2020-12-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF SOUTHERN CALIFORNIA
NIH #5R01ES029092-02
Molecular Mechanism of UV Protection in Cutaneous Melanoma
- Amount
- $121K
- Period
- 2019-01-01 → 2020-06-29
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF SOUTHERN CALIFORNIA
NIH #1R01CA238457-01A1
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC
- Amount
- $191K
- Period
- 2019-12-01 → 2020-06-29
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF SOUTHERN CALIFORNIA
NIH #5R21DE028256-02
Targeting the host NDP kinase to abrogate viral dissemination
- Amount
- $63K
- Period
- 2019-01-04 → 2020-06-29
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF SOUTHERN CALIFORNIA
NIH #5R01CA140964-10
Novel mechanism for UVRAG in genome stability and tumor suppression
- Amount
- $218K
- Period
- 2009-09-21 → 2020-06-29
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF SOUTHERN CALIFORNIA
NIH #5R01CA140964-09
Novel mechanism for UVRAG in genome stability and tumor suppression
- Amount
- $400K
- Period
- 2009-09-21 → 2019-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF SOUTHERN CALIFORNIA
NIH #5R01CA140964-08
Novel mechanism for UVRAG in genome stability and tumor suppression
- Amount
- $353K
- Period
- 2009-09-21 → 2019-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF SOUTHERN CALIFORNIA
NIH #5R01CA140964-07
Novel mechanism for UVRAG in genome stability and tumor suppression
- Amount
- $353K
- Period
- 2009-09-21 → 2019-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF SOUTHERN CALIFORNIA
NIH #2R01CA140964-06
Novel mechanism for UVRAG in genome stability and tumor suppression
- Amount
- $320K
- Period
- 2009-09-21 → 2019-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF SOUTHERN CALIFORNIA
NIH #5R01CA175480-05
Tumor-targeted Polymersomes to image and Treat Ovarian Cancer
- Amount
- $328K
- Period
- 2013-08-13 → 2019-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PENNSYLVANIA
NIH #4R01CA175480-04
Tumor-targeted Polymersomes to image and Treat Ovarian Cancer
- Amount
- $328K
- Period
- 2013-08-13 → 2018-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PENNSYLVANIA
NIH #5R01CA175480-03
Tumor-targeted Polymersomes to image and Treat Ovarian Cancer
- Amount
- $328K
- Period
- 2013-08-13 → 2016-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PENNSYLVANIA